# The Potential of Volatilomics as Female Fertilization Biomarkers in Assisted Reproductive Techniques

**Authors:** Ana Teresa Brinca, Maria Manuel Casteleiro Alves, Ana M. Peiró, Pilar Matallín Evangelio, Irene Eleno Buendicho, Antonio Helio Oliani, Vladimiro Silva, Ana Torgal, Luís F. Vicente, Ana Cristina Ramalhinho, Eugenia Gallardo

PMC · DOI: 10.3390/biomedicines14020264 · Biomedicines · 2026-01-24

## TL;DR

This study explores how volatile organic compounds in follicular fluid could serve as non-invasive biomarkers for female fertility and ART success.

## Contribution

The study identifies specific VOCs in follicular fluid associated with reproductive parameters, offering new insights for infertility biomarkers.

## Key findings

- 45 VOCs were significantly correlated with 11 female fertilization-related parameters.
- VOCs included alkanes, siloxanes, and esters, linked to overlapping metabolic pathways.
- VOC analysis shows potential for improving ART outcomes through follicular physiology insights.

## Abstract

Background/Objectives: Volatile organic compounds (VOCs) have emerged as promising non-invasive biomarkers for assessing metabolic and reproductive health. In the context of assisted reproductive techniques (ARTs), the volatilomic composition of follicular fluid (FF) may reflect the biochemical environment surrounding the oocyte, influencing fertilization success and embryo development. This study aimed to characterize the volatilomic profile of FF in women undergoing ARTs and to explore associations between specific VOCs and female fertilization-related parameters (FFRPs). Methods: A total of 54 Caucasian women aged 19–39 years, enrolled between October 2015 and July 2019, were recruited at the Assisted Reproduction Laboratory of the Local Health Unit of Cova da Beira, Covilhã. FF samples were analyzed via gas chromatography–mass spectrometry (GC–MS) in scan mode, identifying 136 VOCs, of which 72 were selected based on prevalence. Sixteen FFRPs were evaluated, including age, body mass index (BMI), smoking habits, infertility factor, oocyte yield, embryo quality, β-hCG levels, country of birth, and reproductive history. Associations between VOCs and FFRPs were assessed using the Chi-square (χ2) test. Results: Significant correlations (p ≤ 0.05) were identified between 45 VOCs and 11 FFRPs. The detected compounds comprised alkanes, siloxanes, aromatics, alcohols, ketones, aldehydes, carboxylic acids and esters, fatty acid derivatives, epoxides, acrylates, nitriles, and sterols. Several VOCs were associated with more than one FFRP, indicating overlapping metabolic pathways that may influence reproductive performance. Conclusions: The volatilomic profile of FF demonstrates significant variability linked to individual reproductive and metabolic factors. VOC analysis may provide novel insights into follicular physiology, representing a promising approach for identifying potential biomarkers of infertility and ART outcomes.

## Full-text entities

- **Genes:** BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649] {aka AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, FSHR (follicle stimulating hormone receptor) [NCBI Gene 2492] {aka FSHR1, FSHRO, LGR1, ODG1}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, HSPA5 (heat shock protein family A (Hsp70) member 5) [NCBI Gene 3309] {aka BIP, GRP78, HEL-S-89n}, LHCGR (luteinizing hormone/choriogonadotropin receptor) [NCBI Gene 3973] {aka HHG, LCGR, LGR2, LH/CG-R, LH/CGR, LHR}, ATR (ATR checkpoint kinase) [NCBI Gene 545] {aka FCTCS, FRP1, MEC1, SCKL, SCKL1}
- **Diseases:** OS (MESH:D000079225), hyperandrogenism (MESH:D017588), POF (MESH:D016649), injury to (MESH:D014947), nicotine (MESH:D014029), inflammation (MESH:D007249), Trichomonas vaginalis infection (MESH:D014245), endometriosis (MESH:D004715), mitochondrial dysfunction (MESH:D028361), tubal obstruction (MESH:D005184), PCOS (MESH:D011085), carcinogenic (MESH:D011230), Dyslipidemia (MESH:D050171), immune dysfunction (MESH:D007154), Infertility (MESH:D007246), hormone-related cancers (MESH:D009369), Endocrine Disruptors (MESH:D004700), sexually transmitted infections (MESH:D012749), neurotoxicity (MESH:D020258), infection (MESH:D007239), social disorder (MESH:D000067404), insulin resistance (MESH:D007333), cytotoxic (MESH:D064420), disrupt reproductive function (MESH:D019958), pregnancy loss (MESH:D000022), adiposity (MESH:D018205), obese (MESH:D009765), respiratory irritation (MESH:D012131), thyroid dysfunction (MESH:D013959), overweight (MESH:D050177), ovarian carcinogenesis (MESH:D010049), thyroid-disrupting (MESH:D013966), genetic abnormalities (MESH:D030342), reproductive disorders (MESH:D060737), metabolic disease (MESH:D008659), IVF (MESH:C566179), infectious diseases (MESH:D003141)
- **Chemicals:** palmitate (MESH:D010168), siloxane (MESH:D012833), Cyclopentasiloxane (MESH:C114768), Stearyl alcohol (MESH:C009316), Undecane (MESH:C022884), Helium (MESH:D006371), Silicon (MESH:D012825), Eicosamethylcyclodecasiloxane (-), DEP (MESH:C007379), Phthalates (MESH:C032279), DPP (MESH:C106479), nitriles (MESH:D009570), DiBP (MESH:C025605), eicosane (MESH:C050821), carboxylic acids (MESH:D002264), 1-Dodecanol (MESH:D007851), Oxirane-hexadecyl (MESH:C099585), estradiol (MESH:D004958), DBP (MESH:D003993), Fatty Acids (MESH:D005227), polymer (MESH:D011108), hydrocarbons (MESH:D006838), phosphatidylcholine (MESH:D010713), nicotine (MESH:D009538), Aromatic Hydrocarbons (MESH:D006841), triglycerides (MESH:D014280), methyl dihydrojasmonate (MESH:C501952), esters (MESH:D004952), linoleic acids (MESH:D008041), ketones (MESH:D007659), Diisooctylphthalate (MESH:C471688), BBP (MESH:C027561), Isopropyl myristate (MESH:C008205), Phenols (MESH:D010636), nonadecane (MESH:C061580), per- and polyfluoroalkyl substances (MESH:D005466), Cyclic Hydrocarbons (MESH:D006844), ethanol-2-dodecyloxy (MESH:D000077423), PDMS (MESH:C013830), amide (MESH:D000577), Phenol (MESH:D019800), Benzene (MESH:D001554), endocannabinoid (MESH:D063388), dodecane (MESH:C007548), sterols (MESH:D013261), prostaglandin E2 (MESH:D015232), DnHP (MESH:C027387), fatty alcohols (MESH:D005233), Palmitic acid (MESH:D019308), testosterone (MESH:D013739), lipid (MESH:D008055), acrylates (MESH:D000179), Octadecanoic acid (MESH:C031183), Decane (MESH:C012867), progesterone (MESH:D011374), DEHP (MESH:D004051), alcohols (MESH:D000438), epoxides (MESH:D004852), 2-ethylhexyl salicylate (MESH:C103422), Oleamide (MESH:C029407)
- **Species:** Mycoplasmoides genitalium (species) [taxon 2097], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938057/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12938057/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938057/full.md

---
Source: https://tomesphere.com/paper/PMC12938057